Timothy Mayopoulos Acquires 50,000 Shares of BLND

Timothy Mayopoulos made a notable purchase of BLND shares, adding 50,000 to his holdings.

Written by EarningsIQ · Published Jun 15, 2026, 5:05 PM EDT

Key Points

Timothy Mayopoulos purchased 50,000 shares of BLND on June 11, 2026.
BLND's stock traded at $1.69 with notable institutional interest from firms like BlackRock and Vanguard.
Analysts from firms like Canaccord Genuity and Citizens maintained buy ratings on BLND.

Timothy Mayopoulos, a key figure associated with BLND, bought 50,000 shares of the company on June 11, 2026. This insider transaction reflects his confidence in BLND, though the specific purchase price wasn't disclosed.

Other Institutional Activity in BLND

Several major institutional investors have been active in BLND. Lightspeed Management Company, L.L.C. held steady with 23.1 million shares valued at about $39.3 million. BlackRock, Inc. trimmed its position by 65,730 shares, leaving it with 16.3 million shares worth approximately $27.7 million. Cypress Point Investment Management LP significantly increased its stake by 2.7 million shares, now holding 14.5 million shares valued at $24.7 million. Vanguard Capital Management LLC entered the scene with 9.7 million shares, worth around $16.4 million.

BLND Stock Snapshot

Shares of BLND traded at around $1.69. While specific financial ratios like P/E are not available, the stock's activity and insider transactions suggest a dynamic interest from both insiders and institutional investors.

Insider Buying and Selling at Blend Labs, Inc.

On June 11, 2026, several insiders were active in trading BLND shares. Timothy Mayopoulos acquired 50,000 shares, while Eric Woersching also purchased the same amount. Conversely, insiders like Gerald Chen, Erin Lantz, and Bryan Edmund Sullivan each sold 50,000 shares. These transactions were not part of any pre-planned trading programs.

Analysts Set New Price Targets

On May 15, 2026, Canaccord Genuity maintained a 'buy' rating for BLND with a price target of $4.50. Earlier in May, Citizens also kept a 'buy' rating with a $4.00 target. Keefe, Bruyette & Woods rated the stock as 'hold,' setting a target at $1.90. UBS and Wells Fargo also maintained their ratings, reflecting a mix of optimism and caution in the analyst community.

Bottom Line

Timothy Mayopoulos's recent purchase of 50,000 BLND shares highlights ongoing insider interest in the company. Institutional investors like BlackRock and Vanguard are actively adjusting their positions, indicating varied strategies. Analyst ratings remain mixed, providing a range of perspectives on BLND's potential. As always with 13F filings and insider trades, these insights reflect past actions and might not represent current positions.